Monitoring the safety and effects of Tezspire in Korea
Part of Immune system & allergy, Lungs & breathing clinical trials.
This study collects information from patients in Korea who are using the asthma medication tezepelumab (Tezspire). The goal is to monitor the medicine's safety and effectiveness in real-world use.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been prescribed tezepelumab (Tezspire) by your doctor for an approved condition, such as severe asthma
- You will receive at least one dose of tezepelumab
- You agree to sign a consent form allowing your treatment data to be collected for this study
- You are not currently taking part in another clinical trial
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows patients with chronic rhinosinusitis with nasal polyps (CRSwNP)—a condition causing blocked sinuses and nasal growths—who are starting a new biologic medication called tezepelumab. Researchers will track how symptoms and quality of life improve over time in everyday medical practice.
This study is testing a medicine called tezepelumab to see how it affects the lining (barrier) of the airways in people with severe asthma, with or without nasal polyps. Tezepelumab is given as an injection and may help reduce inflammation and improve asthma control.
This study tracks how well tezepelumab works for people with chronic sinusitis and nasal polyps in real-world settings. It aims to see if this medication reduces symptoms and the need for surgery.
This study tests a drug called tezepelumab for people with severe asthma that is not well controlled with current treatments. It aims to see if adding this drug can reduce asthma attacks and improve symptoms.
This trial tests if a drug called Tezepelumab can help adults with asthma who visit the emergency room. It aims to reduce severe asthma attacks and improve breathing control.
This trial looks at whether people with severe asthma who are taking the biologic tezepelumab can safely reduce their use of inhaled corticosteroids (ICS). It aims to see if reducing or stopping ICS affects asthma symptoms or flare-ups.
Hear when a new Severe Asthma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.